Palisade Bio (PALI) Free Cash Flow (2010 - 2026)
Palisade Bio (PALI) reported Free Cash Flow of -$3.9 million for Q1 2026, down 66.74% year-over-year from -$11.7 million in Q1 2025, and down 23.73% quarter-over-quarter from -$3.1 million in Q4 2025.
Palisade Bio (PALI) Free Cash Flow (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Free Cash Flow data on file, last reported at -$3.9 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$3.9 million, down 66.74% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.4 million (down 9.32% YoY), and the FY2025 annual result was -$10.8 million, up 11.04% from the prior year.
- Free Cash Flow retreated to -$3.9 million in Q1 2026 per PALI's latest filing, from -$3.1 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$1.8 million in Q2 2025 and troughed at -$3.9 million in Q1 2026.
- A 5-year average of -$3.0 million and a median of -$3.1 million in 2025 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 57.91% in 2022 and fell as far as 201.12% in 2022.
- A 5-year view of Free Cash Flow shows it stood at -$3.3 million in 2022, then rose by 17.19% to -$2.7 million in 2023, then grew by 13.29% to -$2.4 million in 2024, then slumped by 32.05% to -$3.1 million in 2025, then slipped by 23.73% to -$3.9 million in 2026.
- Business Quant data shows PALI's Free Cash Flow at -$3.9 million in Q1 2026, -$3.1 million in Q4 2025, and -$3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | -3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.89 Mn |
| Mar 31, 2026 | -3.89 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -2.75 Mn |
| Dec 31, 2023 | -2.75 Mn |